课题基金 / 基金详情

Task X14: Evaluation of Ebola Vaccines

Task X14: Evaluation of Ebola Vaccines
任务 X14：埃博拉疫苗的评估
批准号：
9555908
负责人：
MARY BRUCE
金额：
$8.93万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
项目状态：
已结题
起止时间：
2015-09-10 至 2018-07-31
来源：
https://reporter.nih.gov/project-details/9555908
关键词：
BioterrorismClinicalCommunicable DiseasesContractsDevelopmentDrug resistanceEbola VaccinesEmerging Communicable DiseasesEvaluationFeasibility StudiesPhaseSamplingServicesTestingToxicity TestsVaccinesVirusassay developmentefficacy testingevaluation/testingimmunogenicitynovel vaccinespathogenproduct developmentsafety testingvaccine development

项目摘要

项目成果

MARY BRUCE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing
Task X13: Evaluation of an E. coli Vaccine Candidate - Immunogenicity Testing
Task X12: Evaluation of Human Tissue Cross-reactivity of Phase I Clinical Trial Serum Samples
Task X14: Evaluation of Ebola Vaccines
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data